Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

OBJECTIVES:

I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Center for Research Resources (NCRR)
• Collaborator: Northwestern University
• Treatments: Arginine Vasopressin; Chlorothiazide

Criteria

PROTOCOL ENTRY CRITERIA:

• Known or suspected congenital nephrogenic diabetes insipidus

• Clinically and genetically unaffected relatives entered as controls

--Patient Characteristics--

• Age: 6 months to 70 years